Evogene Ltd.(EVGN)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,593 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
EVGN Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Evogene Ltd. (EVGN), a Materials sector company. 13F Pro's AI-powered ranking engine scores EVGN at 27.1/100 on a 32-signal composite quality model, placing it at rank #2,593 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), Evogene Ltd. reports quarterly revenue of $3.9M, net income of $-7.8M. Top institutional holders of EVGN by reported 13-F value include SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS, XTX Topco Ltd, based on the most recent SEC filings. EVGN trades on the Nasdaq exchange and files with the SEC under CIK 1574565. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EVGN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Evogene Ltd. directly from SEC EDGAR.
Revenue
FY 2025
$3.9M
Net Income
FY 2025
$-7.8M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-30.9% YoYTotal Assets
-49.7% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.9M -30.9% | $5.6M +87.0% | $3.0M +78.0% | $1.7M +80.1% | $930.0K -10.6% | $1.0M |
| Total Assets | $20.0M -49.7% | $39.9M -22.0% | $51.1M -9.0% | $56.1M -26.4% | $76.3M +6.1% | $71.9M |
Get alerted when EVGN's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Evogene Ltd. including:
Top Institutional Holders of EVGN
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$33.9K80,078 shCITADEL ADVISORS LLC
$21.4K50,526 shXTX Topco Ltd
$8.2K19,404 shUBS Group AG
$4.7K10,790 shDaytona Street Capital LLC
$4.7K9,253 shBNP PARIBAS FINANCIAL MARKETS
$1.2K2,830 shMORGAN STANLEY
$564.001,285 shFederation des caisses Desjardins du Quebec
$220.00500 shHRT FINANCIAL LP
$45.00107,198 shOSAIC HOLDINGS, INC.
$44.00100 sh
| Fund | Value | Shares |
|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $33.9K | 80,078 |
| CITADEL ADVISORS LLC | $21.4K | 50,526 |
| XTX Topco Ltd | $8.2K | 19,404 |
| UBS Group AG | $4.7K | 10,790 |
| Daytona Street Capital LLC | $4.7K | 9,253 |
| BNP PARIBAS FINANCIAL MARKETS | $1.2K | 2,830 |
| MORGAN STANLEY | $564.00 | 1,285 |
| Federation des caisses Desjardins du Quebec | $220.00 | 500 |
| HRT FINANCIAL LP | $45.00 | 107,198 |
| OSAIC HOLDINGS, INC. | $44.00 | 100 |
More Materials Companies
View all Materials →Put EVGN on your watchlist
Track score changes the day Evogene Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is EVGN a good stock to buy?
13F Pro's AI-powered analysis of Evogene Ltd. (EVGN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Materials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EVGN are available on the EVGN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. EVGN is classified as a small company.
Which hedge funds own EVGN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EVGN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Evogene Ltd.'s investment landscape.